INS and hyperlipidemia: However, hyperlipidemia with increased hepatic levels of CHOL and TGs and fat vacuoles were seen in AuNPs-treated rats, suggesting a hyperlipidemic effect independent of modulating peripheral glucose or insulin signaling.